Drug Database
Back to search

United Kingdom· GB-APID-2859611000001108

Hydroxocobalamin 1mg/1ml solution for injection ampoules

A hydroxocobalamin product containing hydroxocobalamin, registered in United Kingdom by Kent Pharma (UK) Ltd. The same ATC class is registered in 11 of our 19 countries.

ATC B03BA03

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedHydroxocobalamin 1mg/1ml solution for…ATCB03BA03REGISTER NO.GB-APID-2859611000001…PACKS LISTED1CHECKEDSeptember 13, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about hydroxocobalaminAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Hydroxocobalamin is registered in 11 of 19 countries.

Countries holding a registration under ATC B03BA03 (hydroxocobalamin), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 6 of them publish a price we can compare per daily dose
Search hydroxocobalamin products by name

Hydroxocobalamin · ATC B03BA03

11 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Hydroxocobalamin
Manufacturer
Kent Pharma (UK) Ltd
Country
United Kingdom (GB)
ATC code
B03BA03
ATC class
Hydroxocobalamin
Defined daily dose
20 mcg, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    9008732009026

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

40 interactions on record for hydroxocobalamin.

Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check hydroxocobalamin against other medicinesHow interaction checks work

Hydroxocobalamin · interactions on record

40 records

  • 2 moderate
  • 38 info

Most severe, free to view

  • ChloramphenicolJ01BA01moderate
  • Arsenic trioxideL01XX27moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Hydroxocobalamin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All hydroxocobalamin products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Erycytol Depot
  • Belgium · Hydroxocobalamine Acetate Sterop
  • Cyprus · Articlox
  • Germany · Depogamma, Lophakomp-B 12-Depot
  • Denmark · Cohemin, Hydroxocobalamin Alternova
  • Spain · Hidroxocobalamina Basi, Megamilbedoce
  • Finland · Cohemin, Hydroxocobalamin G.L. Pharma
  • France · Dodecavit, Novobedouze
  • Greece · Articlox
  • Ireland · Hydroxocobalamin G.L. Pharma, Hydroxy-Vit
  • Iceland · Cyanokit, Hydroxocobalamin G.L. Pharma
  • Italy · Neo Cytamen
  • Liechtenstein · Cyanokit
  • Malta · Articlox
  • Netherlands · Hydrocobamine, Hydroxocobalamine Focus Care
  • Norway · Cyanokit, Hydroxocobalamin Basi
  • Portugal · Hidroxocobalamina Basi
  • Sweden · Hydroxocobalamin Alternova, Hydroxocobalamin G.L. Pharma
  • Slovenia · Hidroksokobalamin Orion

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ebedbfc6-92ee-4ea3-ac18-2dd0c9d1b8f5
GET /v1/drugs/ebedbfc6-92ee-4ea3-ac18-2dd0c9d1b8f5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "2859611000001108",
  "desc": "Hydroxocobalamin 1mg/1ml solution for injection ampoules (Kent Pharma (UK) Ltd)",
  "form": "Solution for injection",
  "vpid": "39111511000001100",
  "source": "dmd",
  "vtm_id": "776268009",
  "strength": "1 mg",
  "substance": "Hydroxocobalamin",
  "ingredient": "Hydroxocobalamin",
  "supplier_code": "2073701000001100"
}
API referenceMCP serverPlans

See everything about hydroxocobalamin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console